Skip to main content
Explore URMC
menu

Luojing Chen, Ph.D.

Contact Information

Phone Numbers

Office: (585) 273-2186

Fax: (585) 442-3214

Research Labs

Dr. Chen's research interests involve B cell signaling pathways. Dr. Chen's laboratory is currentlyf ocusing on the role of PKK (a protein kinase) in lymphoma and lupus.

Visit Dr. Chen's research interests involve B cell signaling pathways. Dr. Chen's laboratory is currentlyf ocusing on the role of PKK (a protein kinase) in lymphoma and lupus. Lab Website

Faculty Appointments

Biography

Dr. Chen's research interests involve B cell signaling pathways. Dr. Chen's laboratory is currently focusing on the role of PKK (a protein kinase) in lymphoma and lupus.

Credentials

Education

1982
BS | China-Wuhan University
Biology

1985
MS | China-Wuhan University
Microbiology

1992
PhD | Iowa State University
Genetics

Post-doctoral Training & Residency

1996 - 2000
Postdoctoral Fellow Signaling Transduction Lab Massachusetts General Hospital Harvard Medical School Charlestown, MA

1995 - 1996
Postdoctoral Fellow Molecular Biology Massachusetts General Hospital Harvard Medical School Boston, MA

1992 - 1995
Postdoctoral Fellow Genetics Department Iowa State University Ames, IA.

VIEW ALL expand_more

Awards

2003 - 2004
Award for Experimental Hematopoietic Program pilot project
Sponsor: University of Rochester
Location: Rochester, NY

1998 - 2000
NIH Training Grant

1998 - 1999
Massachusetts General Hospital Medical Discovery Award
Sponsor: Massachusetts General Hospital
Location: Boston, MA

1991
Fung Endowment Fellowship
Sponsor: Dept of Zoology and Genetics
Location: Iowa State University

VIEW ALL expand_more

Patents

Patent Title: Methods of Treating B-Cell Cancers
Patent #: 8,367,633
Issue Date: Feb 05, 2013
Country: United States
Invented By: Luojing Chen, Jiyong Zhao

Publications

Journal Articles

1/5/2021
Krieger NS, Asplin J, Granja I, Chen L, Spataru D, Wu TT, Grynpas M, Bushinsky DA. "Chlorthalidone with potassium citrate decreases calcium oxalate stones and increases bone quality in genetic hypercalciuric stone-forming rats." Kidney international.. 2021 Jan 5; Epub 2021 Jan 05.

11/4/2020
Krieger NS, Chen L, Becker J, Chan M, Bushinsky DA. "Deletion of the proton receptor OGR1 in mouse osteoclasts impairs metabolic acidosis-induced bone resorption." Kidney international.. 2020 Nov 4; Epub 2020 Nov 04.

4/2020
Krieger NS, Chen L, Becker J, DeBoyace S, Wang H, Favus MJ, Bushinsky DA. "Increased Osteoclast and Decreased Osteoblast Activity Causes Reduced Bone Mineral Density and Quality in Genetic Hypercalciuric Stone-Forming Rats." . 2020 Apr 0; 4(4):e10350. Epub 2020 Feb 25.

VIEW ALL PUBLICATIONS